image credit: Pixabay

Stents price capping has improved its accessibility: Drug pricing regulator NPPA

February 26, 2020


Price caps on cardiac stents imposed by the government has improved its accessibility, drug pricing regulator said Wednesday.

According to the National Pharmaceutical Pricing Authority (NPPA) both stent manufactured and imported went up from 9.36 lakh in 2016 to 13.55 lakh in 2019. ”Indicating increased access because of price capping by NPPA,” it tweeted.

After a few revisions in last three years, a bare metal stent (BMS) is currently priced at Rs 8,261, and a drug eluting stent (DES) costs Rs 30,080.

Read More on The Economic Times